Epidemiology of Viral Hepatitis Among Subjects in Precarious

Sponsor

University Hospital, Montpellier (Other)

Overall Status

Completed

CT.gov ID

NCT02907905

Collaborator

(none)

200

Enrollment

Location

Arm

Actual Duration (Months)

4.4

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Social insecurity is a significant cost in human terms (health and societal), it defines evil and can be identified as difficulties accessing health and especially water.

We chose to take stock of these populations defined by difficulties accessing water as precarious setting. Subjects homeless population fall into this by accident of life, a life "homeless" or migrant subjects often illegally having only transitory access (associative or charitable structures host) the conditions precarious sanitation including drinking water or toilet. Populations of slums in the same conditions or the presence rationed water (one tap for 150 people) restricts hygiene.

Condition or Disease	Intervention/Treatment	Phase
Social Insecurity	Biological: capillary sampling	N/A

Detailed Description

Social insecurity is a significant cost in human terms (health and societal), it defines evil and can be identified as difficulties accessing health and especially water.

The sampling system as part of a consultation in routine care (will be in DBS (blotter) only alternative to invasive venous sample and requiring heavier care facility. The capillary sampling on filter will also detect a marker of malnutrition .

Thus in live in large social precariousness adult this study should show which interventions in public health and management proposals are most appropriate for this population.

Study Design

Study Type:

Interventional

Actual Enrollment :

200 participants

Allocation:

N/A

Intervention Model:

Single Group Assignment

Masking:

None (Open Label)

Primary Purpose:

Diagnostic

Official Title:

Epidemiology of Hepatitis A,B and C Virus by Dried Blood Spot in Homeless Population

Actual Study Start Date :

Mar 1, 2016

Actual Primary Completion Date :

Nov 1, 2019

Actual Study Completion Date :

Dec 1, 2019

Arms and Interventions

Arm	Intervention/Treatment
Other: Population homeless or living in slum Population homeless or living in slum realizing realizing a capillary sampling	Biological: capillary sampling After elution in buffer (PBS-Tween azide and thiamol) eluate 200 microliter is processed on automated techniques (Siemens Centaur XL and Diasorin) after adjustment of the figures according to ISO 15189 scope B. The results are qualitatively made and sent to the teams. The return of results, a proposal for appropriate care in the event of contact with virus (anti-HAV HCV HBV) through a rendering consultation results

Arm

Intervention/Treatment

Other: Population homeless or living in slum

Population homeless or living in slum realizing realizing a capillary sampling

Biological: capillary sampling

After elution in buffer (PBS-Tween azide and thiamol) eluate 200 microliter is processed on automated techniques (Siemens Centaur XL and Diasorin) after adjustment of the figures according to ISO 15189 scope B. The results are qualitatively made and sent to the teams. The return of results, a proposal for appropriate care in the event of contact with virus (anti-HAV HCV HBV) through a rendering consultation results

Outcome Measures

Primary Outcome Measures

serology HBV [1 day]
Study prevalence HBV in these precarious populations
serology HCV [1 day]
Study prevalence HCV in these precarious populations
serology HAV [1 day]
Study prevalence HAV in these precarious populations

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 100 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Population homeless (SDF)
Population living in slums.

Exclusion Criteria:

Pregnant or lactating women

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	DUCOS	Montpellier		France	34295

Sponsors and Collaborators

University Hospital, Montpellier

Investigators

Study Director: Jacques Ducos, MD PhD, University Hospital, Montpellier

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

University Hospital, Montpellier

ClinicalTrials.gov Identifier:

NCT02907905

Other Study ID Numbers:

9609

First Posted:

Sep 20, 2016

Last Update Posted:

Aug 11, 2022

Last Verified:

Aug 1, 2022

Individual Participant Data (IPD) Sharing Statement:

Undecided

Plan to Share IPD:

Undecided

Additional relevant MeSH terms:

Hepatitis

Study Results

No Results Posted as of Aug 11, 2022